Cargando…

Focal Segmental Sclerosis Associated with the Novel Multi-tyrosine Kinase Inhibitor Ponatinib

Ponatinib is a novel multi-tyrosine kinase inhibitor (TKI) with potent inhibitory activity against refractory chronic myeloid leukemia (CML). Despite its high clinical efficacy, ponatinib induces various adverse events due to its multi-target characteristic. However, renal complications associated w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arai, Hiroyuki, Yamamoto, Shinya, Matsubara, Takeshi, Miyake, Takafumi, Tochio, Akira, Mii, Akiko, Shimizu, Akira, Minamiguchi, Sachiko, Muso, Eri, Yanagita, Motoko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2023
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10569927/ https://www.ncbi.nlm.nih.gov/pubmed/36642524 http://dx.doi.org/10.2169/internalmedicine.1283-22

Ejemplares similares

Diverse Alterations of Glomerular Capillary Networks in Focal Segmental Glomerular Sclerosis
por: Morita, Megumi, et al.
Publicado: (2022)

A report of three cases of patients with tubulointerstitial nephritis with IgM-positive plasma cells, treatment, and serum-IgM as a sensitive marker for relapse
por: Akagi, Ryota, et al.
Publicado: (2023)

Glomerular Endothelial Cell Injury and Focal Segmental Glomerulosclerosis Lesion in Idiopathic Membranous Nephropathy
por: Morita, Megumi, et al.
Publicado: (2015)

Ponatinib and other CML Tyrosine Kinase Inhibitors in Thrombosis
por: Zeng, Peng, et al.
Publicado: (2020)

The severity of glomerular endothelial cell injury is associated with infiltrating macrophage heterogeneity in endocapillary proliferative glomerulonephritis
por: Arai, Momoko, et al.
Publicado: (2021)

Monoclonal gammopathy of renal significance (MGRS)-related AL amyloidosis complicated by amyloid myopathy: a case report
por: Ono, Erina, et al.
Publicado: (2021)

Combination of panobinostat with ponatinib synergistically overcomes imatinib‐resistant CML cells
por: Matsuda, Yasufumi, et al.
Publicado: (2016)

Ponatinib: a novel multi-tyrosine kinase inhibitor against human malignancies
por: Tan, Fiona H, et al.
Publicado: (2019)

Autophagic flux inhibition enhances cytotoxicity of the receptor tyrosine kinase inhibitor ponatinib
por: Corallo, Diana, et al.
Publicado: (2020)

Receptor-Tyrosine Kinase Inhibitor Ponatinib Inhibits Meningioma Growth In Vitro and In Vivo
por: Yu, Tao, et al.
Publicado: (2021)

A Rare Case of Blindness Caused by Syphilis with Malignant Hypertensive Nephropathy
por: Matsumoto, Minami, et al.
Publicado: (2023)

Severe TAFRO Syndrome Mimicking Hepatorenal Syndrome Successfully Treated with a Multidisciplinary Approach: A Case Report and Literature Review
por: Yamamoto, Shinya, et al.
Publicado: (2023)

All tyrosine kinase inhibitor-resistant chronic myelogenous cells are highly sensitive to Ponatinib
por: Cassuto, Ophélie, et al.
Publicado: (2012)

Membranous Nephropathy-Like Apolipoprotein E Deposition Disease with Apolipoprotein E Toyonaka (Ser197Cys) and a Homozygous Apolipoprotein E2/2
por: Fukunaga, Megumu, et al.
Publicado: (2018)

Ponatinib‐induced ichthyosiform eruption
por: Kluger, Nicolas, et al.
Publicado: (2021)

mTORC1-Inhibition Potentiating Metabolic Block by Tyrosine Kinase Inhibitor Ponatinib in Multiple Myeloma
por: Nazim, Uddin Md., et al.
Publicado: (2022)

Modelling ponatinib resistance in tyrosine kinase inhibitor-naïve and dasatinib resistant BCR-ABL1+ cell lines
por: Lu, Liu, et al.
Publicado: (2018)

Ponatinib after failure of second‐generation tyrosine kinase inhibitor in resistant chronic‐phase chronic myeloid leukemia
por: Kantarjian, Hagop M., et al.
Publicado: (2022)

S153: MECHANISMS OF TROMBOGENESIS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA UNDER TREATMENT WITH PONATINIB AND OTHER TYROSINE KINASE INHIBITORS
por: José Cuenca Zamora, Ernesto, et al.
Publicado: (2023)

Eruptive melanocytic nevi associated with ponatinib
por: Devred, Inès, et al.
Publicado: (2018)

Ponatinib-Induced Cerebrovascular Accident (CVA)
por: Azad, Farhan, et al.
Publicado: (2022)

Reengineering Ponatinib to Minimize Cardiovascular Toxicity
por: Hnatiuk, Anna P., et al.
Publicado: (2022)

Evaluation of Kidney Histological Images Using Unsupervised Deep Learning
por: Sato, Noriaki, et al.
Publicado: (2021)

The effects of ponatinib, a multi-targeted tyrosine kinase inhibitor, against human U87 malignant glioblastoma cells
por: Zhang, Junxia, et al.
Publicado: (2014)

Beneficial effect of LDL-apheresis in refractory nephrotic syndrome
por: Muso, Eri
Publicado: (2014)

Tyrosine phosphorylation–dependent activation of TRPC6 regulated by PLC-γ1 and nephrin: effect of mutations associated with focal segmental glomerulosclerosis
por: Kanda, Shoichiro, et al.
Publicado: (2011)

Renal Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplantation: Involvement of Chronic Graft-Versus-Host Disease
por: Mii, Akiko, et al.
Publicado: (2018)

Calcium channel blocker in patients with chronic kidney disease
por: Ohno, Shoko, et al.
Publicado: (2021)

Effects of Ketoconazole on the Pharmacokinetics of Ponatinib in Healthy Subjects
por: Narasimhan, Narayana I, et al.
Publicado: (2013)

Effects of food on the pharmacokinetics of ponatinib in healthy subjects
por: Narasimhan, NI, et al.
Publicado: (2013)

Fibroblast heterogeneity and tertiary lymphoid tissues in the kidney
por: Arai, Hiroyuki, et al.
Publicado: (2021)

A Refractory Case of Secondary Membranous Nephropathy Concurrent with IgG4-related Tubulointerstitial Nephritis
por: Arai, Hiroyuki, et al.
Publicado: (2018)

Focal segmental glomerulosclerosis lesion associated with inhibition of tyrosine kinases by lenvatinib: a case report
por: Furuto, Yoshitaka, et al.
Publicado: (2018)

Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis Superimposed on Post-streptococcal Acute Glomerulonephritis
por: Kamijo, Natsumi, et al.
Publicado: (2022)

Novel multiple tyrosine kinase inhibitor ponatinib inhibits bFGF-activated signaling in neuroblastoma cells and suppresses neuroblastoma growth in vivo
por: Li, Haoyu, et al.
Publicado: (2016)

A Case of Podocytic Infolding Glomerulopathy with Focal Segmental Glomerulosclerosis
por: Iguchi, Akira, et al.
Publicado: (2013)

A case of nephrotic syndrome showing contemporary presence of apolipoprotein E2 homozygote glomerulopathy and membranous nephropathy-like findings modified by apolipoprotein E Toyonaka
por: Hirashima, Hisako, et al.
Publicado: (2018)

Twisted Gastrulation, a BMP Antagonist, Exacerbates Podocyte Injury
por: Yamada, Sachiko, et al.
Publicado: (2014)

Resistant mutations in CML and Ph(+)ALL – role of ponatinib
por: Miller, Geoffrey D, et al.
Publicado: (2014)

Permissive untreated pseudoaneurysm concept in damage control interventional radiology for traumatic pancreaticoduodenal artery injury
por: Yonemitsu, Takafumi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_129lgl5r2ej1oahmvo931o9fti